The Role of the Pharmacist in T2D: The Evolution of Insulin Therapy


The Role of the Pharmacist in T2D: The Evolution of Insulin Therapy

Topic: Diabetology
Relevant Terms: Type 2 diabetes; insulin therapy
Primary Audience: Pharmacists
Launch Date: 18-Jan-18
Credits: 1 ACPE contact hour
Expiration Date: 18-Jan-19
Curriculum Name: The Role of the Pharmacist in T2D: The Evolution of Insulin Therapy

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Summarize the current evidence-based practice guidelines for the management of type 2 diabetes (T2D).
  2. Describe barriers to insulin initiation and insulin intensification in patients with T2D.
  3. Review strategies to overcome barriers to successful insulin initiation and intensification.
  4. Describe the current and new insulin therapies and those in late-stage development for the management of T2D.


    Joshua J. Neumiller, PharmD, CDE, FASCP
    Vice-Chair & Associate Professor, Department of Pharmacotherapy
    Director of Experiential Services
    Editor-in-Chief, Diabetes Spectrum
    Washington State University, College of Pharmacy
    Spokane, WA
    Candis M. Morello, PharmD, CDE, FCSHP, FASHP
    Professor of Clinical Pharmacy
    Associate Dean for Student Affairs
    University of California San Diego
    Skaggs School of Pharmacy and Pharmaceutical Sciences
    San Diego, CA

    Joshua J. Neumiller, PharmD, CDE, FASCP, has no relevant affiliations or financial relationships with a commercial interest to disclose.
    Candis M. Morello, PharmD, CDE, FCSHP, FASHP, has no relevant affiliations or financial relationships with a commercial interest to disclose.
    The planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of this continuing education (CE) activity hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. We are committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.
     In support of improving patient care, Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the healthcare team.

    Rush University Medical Center designates this knowledge based CPE activity (J0000275-0000-18-003-H01-P) for 1 contact hours for pharmacists.
    UAN: J0000275-0000-18-003-H01-P
    Credits: 1.0 hour (0.10 ceu)
    Published: January 18, 2018
    Expires: January 18, 2019
    Type of Activity: Knowledge
    Media: Internet
    Estimated time to complete activity: 60 minutes
    Fee Information: There is no fee for this educational activity.

    During the period January 18, 2018 through January 18, 2019, participants must 1) read the learning objectives and faculty disclosures; 2) view the educational activity in its entirety; and 3) complete the post-test and evaluation form directly after the activity within a maximum of 60 days of participating in the activity. If you successfully complete the post-test (score of 70% or higher), your statement of participation will be made available immediately. 
    This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC. 

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Rush University Medical Center, MCM Education, Boehringer Ingelheim Pharmaceuticals, Inc., or Lilly USA, LLC. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions, and possible contraindications on dangers in use, (review of any applicable manufacturer's product information) and comparison with recommendations of other authorities.
    The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this activity have not been evaluated by the FDA. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.
    Supported Browsers:
    Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
    Google Chrome 28.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
    Safari 6.0+ for Mac OSX 10.7 and above
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above.